|
Volumn 10, Issue 4, 1987, Pages 355-359
|
Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FOLINIC ACID;
KETOCONAZOLE;
MACOP B PROTOCOL;
MACOP-B PROTOCOL;
METHOTREXATE;
NYSTATIN;
PREDNISONE;
VINCRISTINE;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MYCOSIS;
NONHODGKIN LYMPHOMA;
PROSPECTIVE STUDY;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
TIME;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
KETOCONAZOLE;
LEUCOVORIN;
LYMPHOMA, NON-HODGKIN;
MALE;
METHOTREXATE;
MIDDLE AGED;
MYCOSES;
NYSTATIN;
PREDNISONE;
PROSPECTIVE STUDIES;
RANDOM ALLOCATION;
TIME FACTORS;
VINCRISTINE;
|
EID: 0023395858
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-198708000-00019 Document Type: Article |
Times cited : (11)
|
References (0)
|